| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |